ERWINAZE Trademark

Trademark Overview

On Wednesday, July 29, 2020, a trademark application was filed for ERWINAZE with the United States Patent and Trademark Office. The USPTO has given the ERWINAZE trademark a serial number of 90081574. The federal status of this trademark filing is REGISTERED as of Tuesday, December 3, 2024. This trademark is owned by Porton Biopharma Limited. The ERWINAZE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for treatment of blood cancer; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations for treatment of leukaemia and cancer, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity
erwinaze

General Information

Serial Number90081574
Word MarkERWINAZE
Filing DateWednesday, July 29, 2020
Status700 - REGISTERED
Status DateTuesday, December 3, 2024
Registration Number7583279
Registration DateTuesday, December 3, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements

Description of MarkThe mark consists of the word "ERWINAZE" to the left of a multi-lined design.
Goods and ServicesPharmaceutical preparations and substances for treatment of blood cancer; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations for treatment of leukaemia and cancer, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePorton Biopharma Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressWiltshire SP40JG
GB
Party NamePorton Biopharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressWiltshire SP40JG
GB
Party NamePorton Biopharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWiltshire SP40JG
GB

Trademark Events

Event DateEvent Description
Saturday, August 1, 2020NEW APPLICATION ENTERED
Tuesday, November 17, 2020ASSIGNED TO EXAMINER
Thursday, August 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 28, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 18, 2020NON-FINAL ACTION WRITTEN
Wednesday, November 18, 2020NON-FINAL ACTION E-MAILED
Wednesday, November 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 2, 2022SOU EXTENSION 1 GRANTED
Tuesday, August 31, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 2, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 2, 2022SOU EXTENSION 1 FILED
Thursday, June 30, 2022SOU EXTENSION 2 FILED
Friday, February 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 30, 2022SOU EXTENSION 2 GRANTED
Tuesday, July 18, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 28, 2023SOU EXTENSION 3 FILED
Tuesday, February 28, 2023SOU EXTENSION 3 GRANTED
Thursday, March 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 18, 2023SOU EXTENSION 4 FILED
Tuesday, July 18, 2023SOU EXTENSION 4 GRANTED
Thursday, February 29, 2024SOU EXTENSION 5 FILED
Thursday, February 29, 2024SOU EXTENSION 5 GRANTED
Thursday, February 29, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 30, 2024TEAS PETITION TO AMEND BASIS RECEIVED
Friday, March 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024ASSIGNED TO PETITION STAFF
Wednesday, July 10, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, August 27, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, August 28, 2024NOTICE OF ALLOWANCE CANCELLED
Wednesday, August 28, 2024CASE RETURNED TO EXAMINATION
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

erwinaze pharmaceutical treatment preparations cancer substances leukaemia compositions having asparaginase activity